CN111825524A - Preparation method and application of cyclic diol containing bridged ring structure - Google Patents

Preparation method and application of cyclic diol containing bridged ring structure Download PDF

Info

Publication number
CN111825524A
CN111825524A CN202010710922.7A CN202010710922A CN111825524A CN 111825524 A CN111825524 A CN 111825524A CN 202010710922 A CN202010710922 A CN 202010710922A CN 111825524 A CN111825524 A CN 111825524A
Authority
CN
China
Prior art keywords
cyclic
ring structure
cyclic diol
bridged ring
catalyst
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010710922.7A
Other languages
Chinese (zh)
Inventor
李燕平
左洪亮
刘阳
张晓超
李红仙
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guangdong Cpd New Material Technology Co ltd
Original Assignee
Guangdong Xinhuayue Petrochemical Inc Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guangdong Xinhuayue Petrochemical Inc Co filed Critical Guangdong Xinhuayue Petrochemical Inc Co
Priority to CN202010710922.7A priority Critical patent/CN111825524A/en
Publication of CN111825524A publication Critical patent/CN111825524A/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/132—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group
    • C07C29/136—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH
    • C07C29/14—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH of a —CHO group
    • C07C29/141—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH of a —CHO group with hydrogen or hydrogen-containing gases
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/49—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reaction with carbon monoxide
    • C07C45/50—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reaction with carbon monoxide by oxo-reactions
    • C07C45/505—Asymmetric hydroformylation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/69—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by addition to carbon-to-carbon double or triple bonds
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/36—Systems containing two condensed rings the rings having more than two atoms in common
    • C07C2602/42—Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing seven carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention relates to a preparation method of cyclic diol, in particular to a preparation method of cyclic diol containing a bridged ring structure and application thereof. The applicant provides a preparation method of cyclic diol containing a bridged ring structure, the prepared diol contains both bridged rings and alicyclic structures, and has a good prospect of synthesizing novel high-performance materials such as novel polyester or polyurethane; in addition, the invention utilizes the mature technology in industry, the designed preparation route has the characteristics of simple and efficient process, and by using the raw materials with low price, the novel dihydric alcohol product with high yield and purity can be obtained under the mild condition, the development cost of the novel material product can be obviously reduced, and an industrialized implementation route is provided for preparing the alicyclic dihydric alcohol product.

Description

Preparation method and application of cyclic diol containing bridged ring structure
Technical Field
The invention relates to a preparation method of cyclic diol, in particular to a preparation method of cyclic diol containing a bridged ring structure and application thereof.
Background
Dihydric alcohol is an important and widely applied basic organic chemical raw material, such as ethylene glycol, propylene glycol, 1, 4-butanediol and the like which are widely applied to producing materials such as polyester fiber, polyester plastic, polyurethane and the like. The dihydric alcohol containing aliphatic cyclic structure is a special dihydroxy compound, and the unique cyclic structure can improve the heat resistance, weather resistance, hardness and other properties of the high polymer material, and has no odor and low toxicity. For example, 1, 4-Cyclohexanedimethanol (CHDM) is alicyclic diol containing a six-membered ring, is an important monomer for synthesizing various high-performance polyester materials, such as PCT, PETG, PCTA and the like, and has the characteristics of excellent thermal stability, good balance of hardness and flexibility, higher glass transition temperature and the like. Dicidol (TCD-DM) is another special alicyclic diol, can be used for synthesizing polymers such as polyacrylate, polyester, epoxy resin, polyurethane and the like, and can endow the polymers with good adhesion, high tensile strength, heat resistance, weather resistance and impact resistance.
At present, the preparation process of the cyclic diol is complex, and the yield and the purity cannot be ensured, so a new preparation method is designed to develop the novel diol, which is beneficial to developing new material products with high technical content, high added value and high performance.
Disclosure of Invention
In order to solve the above problems, the first aspect of the present invention provides a method for preparing a cyclic diol having a bridged ring structure, wherein the cyclic diol is represented by formula (1) and/or formula (2):
Figure BDA0002596514620000011
R1、R2respectively hydrogen atom or C1-C6 alkyl.
As a preferable technical scheme of the invention, the cyclic diol is obtained by catalytic hydrogenation of a dialdehyde intermediate, and the dialdehyde intermediate is shown as a formula (3) and/or a formula (4):
Figure BDA0002596514620000021
R1、R2respectively hydrogen atom or C1-C6 alkyl.
As a preferred technical scheme, in the catalytic hydrogenation, the reaction pressure is 1-10 MPa, and the reaction temperature is 80-150 ℃.
As a preferred technical solution of the present invention, the dialdehyde intermediate is obtained by hydroformylation of a monoaldehyde cyclic olefin, which is represented by formula (5) and/or formula (6):
Figure BDA0002596514620000022
R1、R2respectively hydrogen atom or C1-C6 alkyl.
In the hydroformylation, the monoaldehyde cycloolefins are reacted with synthesis gas under the action of a hydroformylation catalyst to obtain a dialdehyde intermediate.
As a preferable technical scheme, in the hydroformylation, the reaction pressure is 1-5 MPa, and the reaction temperature is 90-150 ℃.
In a preferred embodiment of the present invention, the hydroformylation catalyst is a combination of a metal salt and organic phosphorus.
As a preferred technical solution of the present invention, the monoaldehyde cyclic olefin is obtained by cycloaddition of a cyclic diene and a monoalkene aldehyde, wherein the cyclic diene is cyclopentadiene and/or 1, 3-cyclohexadiene, and the monoalkene aldehyde is represented by formula (7):
Figure BDA0002596514620000023
r is hydrogen atom or C1-C6 alkyl.
In a preferred embodiment of the present invention, the molar ratio of the cyclic diene to the monoolefin aldehyde is 1: (1-1.5).
The second aspect of the invention provides an application of the preparation method of the cyclic diol containing the bridged ring structure, which is used for preparing macromolecules.
Compared with the prior art, the invention has the following beneficial effects: the applicant provides a preparation method of cyclic diol containing a bridged ring structure, the prepared diol contains both bridged rings and alicyclic structures, and has a good prospect of synthesizing novel high-performance materials such as novel polyester or polyurethane; in addition, the invention utilizes the mature technology in industry, the designed preparation route has the characteristics of simple and efficient process, and by using the raw materials with low price, the novel dihydric alcohol product with high yield and purity can be obtained under the mild condition, the development cost of the novel material product can be obviously reduced, and an industrialized implementation route is provided for preparing the alicyclic dihydric alcohol product.
Detailed Description
The disclosure may be understood more readily by reference to the following detailed description of preferred embodiments of the invention and the examples included therein. Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. In case of conflict, the present specification, including definitions, will control.
The term "prepared from …" as used herein is synonymous with "comprising". The terms "comprises," "comprising," "includes," "including," "has," "having," "contains," "containing," or any other variation thereof, as used herein, are intended to cover a non-exclusive inclusion. For example, a composition, process, method, article, or apparatus that comprises a list of elements is not necessarily limited to only those elements but may include other elements not expressly listed or inherent to such composition, process, method, article, or apparatus.
The conjunction "consisting of …" excludes any unspecified elements, steps or components. If used in a claim, the phrase is intended to claim as closed, meaning that it does not contain materials other than those described, except for the conventional impurities associated therewith. When the phrase "consisting of …" appears in a clause of the subject matter of the claims rather than immediately after the subject matter, it defines only the elements described in the clause; other elements are not excluded from the claims as a whole.
When an amount, concentration, or other value or parameter is expressed as a range, preferred range, or as a range of upper preferable values and lower preferable values, this is to be understood as specifically disclosing all ranges formed from any pair of any upper range limit or preferred value and any lower range limit or preferred value, regardless of whether ranges are separately disclosed. For example, when a range of "1 to 5" is disclosed, the described range should be interpreted to include the ranges "1 to 4", "1 to 3", "1 to 2 and 4 to 5", "1 to 3 and 5", and the like. When a range of values is described herein, unless otherwise stated, the range is intended to include the endpoints thereof and all integers and fractions within the range.
The singular forms "a", "an" and "the" include plural referents unless the context clearly dictates otherwise. "optional" or "any" means that the subsequently described event or events may or may not occur, and that the description includes instances where the event occurs and instances where it does not.
Approximating language, as used herein throughout the specification and claims, is intended to modify a quantity, such that the invention is not limited to the specific quantity, but includes portions that are literally received for modification without substantial change in the basic function to which the invention is related. Accordingly, the use of "about" to modify a numerical value means that the invention is not limited to the precise value. In some instances, the approximating language may correspond to the precision of an instrument for measuring the value. In the present description and claims, range limitations may be combined and/or interchanged, including all sub-ranges contained therein if not otherwise stated.
In addition, the indefinite articles "a" and "an" preceding an element or component of the invention are not intended to limit the number requirement (i.e., the number of occurrences) of the element or component. Thus, "a" or "an" should be read to include one or at least one, and the singular form of an element or component also includes the plural unless the stated number clearly indicates that the singular form is intended.
The present invention is illustrated by the following specific embodiments, but is not limited to the specific examples given below.
The first aspect of the present invention provides a method for preparing a cyclic diol containing a bridged ring structure, wherein the cyclic diol is represented by formula (1) and/or formula (2):
Figure BDA0002596514620000041
R1、R2are respectively hydrogen atom or C1-C6 alkyl; further, R1、R2Respectively hydrogen atom or methyl.
In one embodiment, the cyclic diol of the present invention is obtained by catalytic hydrogenation of a dialdehyde intermediate, which is represented by formula (3) and/or formula (4):
Figure BDA0002596514620000051
R1、R2are respectively hydrogen atom or C1-C6 alkyl; further, R1、R2Respectively hydrogen atom or methyl.
Catalytic hydrogenation
In one embodiment, in the catalytic hydrogenation, the reaction pressure is 1-10 MPa, and the reaction temperature is 80-150 ℃; further, in the catalytic hydrogenation, the reaction pressure is 1-4 MPa, and the reaction temperature is 80-130 ℃.
Preferably, in the catalytic hydrogenation of the present invention, the catalytic hydrogenation catalyst is one of a nickel-based catalyst, a palladium-based catalyst, a platinum-based catalyst, a silver-based catalyst, a ruthenium-based catalyst, and a germanium-based catalyst. The catalytic hydrogenation catalyst is not particularly limited, and in one embodiment, the catalytic hydrogenation catalyst is one of a nickel-based catalyst, a palladium-based catalyst and a platinum-based catalyst; examples of catalytic hydrogenation catalysts include, but are not limited to, raney nickel, supported catalytic hydrogenation catalysts. The supported catalytic hydrogenation catalyst comprises a metal and a carrier, wherein the metal is selected from nickel, palladium and platinum; further, in the supported catalytic hydrogenation catalyst, the metal accounts for 3-8 wt% of the supported catalytic hydrogenation catalyst; the carrier of the present invention is not particularly limited, and may be any carrier known in the art, and examples thereof include carbon, alumina, silica gel, diatomaceous earth, zeolite molecular sieves, activated carbon, titania, lithium aluminate, and zirconia.
More preferably, the catalytic hydrogenation catalyst accounts for 4-8% of the weight of the dialdehyde intermediate.
Further preferably, in the catalytic hydrogenation of the present invention, the catalytic hydrogenation solvent is one selected from tetrahydrofuran, dichloromethane, 1, 4-dioxane, methanol, and ethanol.
Further preferably, in the catalytic hydrogenation, the dialdehyde intermediate, the catalytic hydrogenation solvent and the catalytic hydrogenation catalyst are added into a catalytic hydrogenation reaction kettle, the air in the reaction kettle is replaced by hydrogen, the reaction is carried out for 3-7 h at 80-150 ℃ and 1-10 MPa, and the cyclic diol is obtained by filtering and distilling.
In one embodiment, the dialdehyde intermediate is obtained by hydroformylation of a monoaldehyde cycloolefin, wherein the monoaldehyde cycloolefin is represented by the formula (5) and/or the formula (6):
Figure BDA0002596514620000061
R1、R2are respectively hydrogen atom or C1-C6 alkyl; further, R1、R2Respectively hydrogen atom or methyl.
Hydroformylation of olefins
In one embodiment, the hydroformylation process of the present invention involves reacting a monoaldehyde cycloolefin with synthesis gas over a hydroformylation catalyst to produce a dialdehyde intermediate.
In one embodiment, the syngas of the present invention comprises CO and H2Is 1: (0.5 to 2); further, in the synthesis gas of the present invention, CO and H2Is 1: 1.
preferably, the hydroformylation catalyst of the present invention is a combination of a metal catalyst and an organic phosphorus; further, the molar ratio of the metal salt catalyst to the organic phosphorus is 1: (1-20); further, the molar ratio of the metal salt catalyst to the organic phosphorus is 1: (1-10).
More preferably, the metal catalyst of the present invention is a cobalt-based catalyst or a rhodium-based catalyst; further, the metal catalyst is a rhodium catalyst; further, the rhodium catalyst is selected from one of rhodium chloride, rhodium nitrate, rhodium acetate, rhodium octanoate, rhodium acetylacetonate carbonyl and dicarbonyl acetylacetonate; furthermore, the molar concentration of the rhodium catalyst in the monoaldehyde cycloolefin is 1-100 ppm; furthermore, the molar concentration of the rhodium catalyst in the monoaldehyde cycloolefin is 40-100 ppm.
The molar concentration of the rhodium-based catalyst in the present invention is a concentration expressed in ppm in terms of parts per million of the molar amount of the monoaldehyde cycloolefin.
Further preferably, the organophosphorus disclosed by the invention is selected from one or more of trialkyl phosphine, triaryl phosphine and organic phosphite; further, the organophosphorus is organic phosphite or triaryl phosphorus; further, the organic phosphite ester is selected from one of triphenyl phosphite, trihexyl phosphite, tris (2,2, 2-trifluoroethyl) phosphite and tris (2, 4-di-tert-butyl) phosphite; further, the organic phosphite ester is selected from one of triphenyl phosphite and tris (2,2, 2-trifluoroethyl) phosphite.
Further preferably, in the hydroformylation, the reaction pressure is 1-5 MPa, and the reaction temperature is 90-150 ℃; furthermore, in the hydroformylation of the invention, the reaction pressure is 2MPa, and the reaction temperature is 110 ℃.
In a preferred embodiment, in the hydroformylation of the present invention, the hydroformylation solvent is selected from one or more of hydrocarbon solvents, ether solvents, alcohol solvents, and heterocyclic solvents. The hydroformylation solvent is not particularly limited, and examples thereof include toluene, cyclohexane, n-hexane, octane, tetrahydrofuran, methyl t-butyl ether, n-heptane, benzene, 1, 3-xylene, 1, 4-xylene, 1,3, 5-trimethylbenzene, naphthalene, methyl isopropyl ether, isoprene glycol, and 1, 4-dioxane.
In a more preferable embodiment, in the hydroformylation, the monoaldehyde cycloolefin and the hydroformylation solvent are added into a hydroformylation reaction kettle, a hydroformylation catalyst is added, the air in the reaction kettle is replaced by synthesis gas, the reaction is carried out for 2-5 h at the temperature of 80-150 ℃ under the pressure of 1-10 MPa, and the dialdehyde intermediate is obtained by reduced pressure distillation.
In one embodiment, the monoaldehyde cyclic olefin of the present invention is obtained by cycloaddition of a cyclic diene and a monoalkene aldehyde, wherein the cyclic diene is cyclopentadiene and/or 1, 3-cyclohexadiene, and the monoalkene aldehyde is represented by formula (7):
Figure BDA0002596514620000071
r is hydrogen atom or C1-C6 alkyl; further, R is a hydrogen atom or a methyl group.
Cycloaddition
In one embodiment, the cyclic diene and monoolefin aldehyde of the present invention are present in a molar ratio of 1: (1-1.5); further, the molar ratio of the cyclic diene to the monoolefin aldehyde according to the present invention is 1: 1.2.
preferably, in the cycloaddition, the reaction temperature is 0-100 ℃.
More preferably, in the cycloaddition, the reaction time is 2-48 h; furthermore, in the cycloaddition, the reaction time is 5-12 h.
Further preferably, in the cycloaddition of the present invention, the cycloaddition catalyst is selected from one of an enzyme catalyst, a metal catalyst and a nonmetal catalyst; further, the cycloaddition catalyst is a non-metal catalyst; further, the cycloaddition catalyst accounts for 0.1-2% of the cyclic diene by mole; further, the cycloaddition catalyst accounts for 1-2% of the cyclic diene by mole; further, the cycloaddition catalyst of the present invention is present in a molar percentage of the cyclic diene of 1.9%.
In one embodiment, the non-metallic catalyst of the present invention is selected from one of a protic acid catalyst, a protic base catalyst, a Lewis acid catalyst, and a Lewis base catalyst. As examples of Lewis acid catalysts, include, but are not limited to, boron trifluoride etherate, trifluoromethanesulfonic acid, tetrafluoroboric acid, trityltetrafluoroborate (TrBF4), tritylhexafluoroborate (TrPF6), trimethylsilanolate trifluoromethanesulfonate (TMSOTf), bis- (trifluoromethanesulfonyl) -iminosilane (TMSNTf 2); examples of Lewis base catalysts include, but are not limited to, N-methylimidazolidone, N-methylimidazole, trimethylphosphine, N-heterocyclic carbenes. In a preferred embodiment, the cycloaddition catalyst of the present invention is a Lewis acid catalyst.
Further preferably, in the cycloaddition of the present invention, the cycloaddition solvent is a solvent well known in the art, and may be, for example, dichloromethane, chloroform, tetrahydrofuran, chlorobenzene, toluene, xylene, ethyl acetate, acetone, or diethylene glycol dimethyl ether.
In a preferred embodiment, in the cycloaddition of the present invention, the polymerization inhibitor is selected from one of p-benzoquinone, p-hydroxyanisole (MEHQ), p-tert-butylcatechol (TBC), tetramethylpiperidine nitroxide radical phosphite triester; further, the polymerization inhibitor accounts for 0.1-0.5 wt% of the monoolefine aldehyde.
In a more preferred embodiment, in the cycloaddition, under the protection of nitrogen, the cyclic diene, the monoolefinic aldehyde, the polymerization inhibitor and the cycloaddition solvent are mixed, the cycloaddition catalyst is added, the mixture reacts at 0-100 ℃ for 2-48 hours, and then the temperature is reduced to room temperature, and the mixture is washed with water, desolventized and rectified under reduced pressure to obtain the monoaldehyde cycloolefin.
The applicant can obtain the cyclic diol with high yield and purity by designing a process route of the cyclic diol and starting from commonly available raw materials of cyclic diene and monoolefin aldehyde and sequentially carrying out mature cycloaddition, hydroformylation and catalytic hydrogenation reaction, and the applicant finds that by adopting a certain proportion of the cyclic diene and the monoolefin aldehyde, because double bonds in the monoolefin aldehyde are connected with acidic aldehyde groups of strong electron-withdrawing groups, the reaction activity of the cycloaddition is increased, the monoaldehyde cycloolefins with high yield and purity can be obtained at lower temperature and in time under the condition of Lewis acid catalysis, the double bonds of the monoaldehyde cycloolefins are subjected to hydroformylation reaction, and one hydrogen and one aldehyde group are respectively added on two sides of the double bonds, wherein the applicant finds that a complex is formed by adding a proper organic phosphorus and a metal catalyst, particularly selects the organic phosphorus and the metal catalyst with larger electronic and steric hindrance substituent to act together, the reaction of the monoaldehyde cycloolefins and the synthesis gas can be promoted under low catalyst concentration and reaction conditions; the applicant finds that when the reaction temperature and time are controlled to carry out catalytic hydrogenation in a hydrogen atmosphere, two aldehyde groups on the dialdehyde intermediate can be completely reduced into alcohol groups, and a diol product containing a bridged ring structure is finally obtained.
In a second aspect, the present invention provides a method for preparing a cyclic diol containing a bridged ring structure, as described above, and an application of the method for preparing a polymer.
In one embodiment, the polymer of the present invention is selected from one or more of polyacrylate, polyester, epoxy, polyurethane, polyurea.
Examples
The present invention will be specifically described below by way of examples. It should be noted that the following examples are only for illustrating the present invention and should not be construed as limiting the scope of the present invention, and that the insubstantial modifications and adaptations of the present invention by those skilled in the art based on the above disclosure are still within the scope of the present invention.
Example 1
This example provides a method for preparing a cyclic diol having a bridged ring structure, comprising:
cycloaddition: under the protection of nitrogen, mixing cyclopentadiene, acrolein, tetramethyl piperidine nitroxide free radical phosphite triester and toluene, adding boron trifluoride diethyl etherate, reacting at 70 ℃ for 8 hours, cooling to room temperature, washing with water, desolventizing, and rectifying under reduced pressure to obtain the monoaldehyde cycloolefine; the mol ratio of the cyclopentadiene to the acrolein is 1: 1.2, the molar percentage of boron trifluoride diethyl etherate in the cyclopentadiene is 1.9 percent, and the weight percentage of the tetramethyl piperidine nitroxide radical phosphite triester in the acrolein is 0.25 percent; the monoaldehyde cycloalkene is shown below:
Figure BDA0002596514620000091
R1is a hydrogen atom;
hydroformylation: adding the mono-aldehyde cycloolefin and the toluene into a hydroformylation reaction kettle, adding a hydroformylation catalyst, replacing air in the reaction kettle with synthesis gas, reacting for 3 hours at the temperature of 110 ℃ under the pressure of 2MPa, and distilling under reduced pressure to obtain a dialdehyde intermediate; in the synthesis gas, CO and H2Is 1: 1, the hydroformylation catalyst is a composition of dicarbonyl acetylacetone rhodium and triphenylphosphine, and the molar ratio is 1: 10, the molar concentration of the metal catalyst in the monoaldehyde cycloolefins is 93 ppm; the dialdehyde intermediate is shown as follows:
Figure BDA0002596514620000092
R1is a hydrogen atom;
catalytic hydrogenation: adding the dialdehyde intermediate, toluene and Raney nickel into a catalytic hydrogenation reaction kettle, replacing air in the reaction kettle with hydrogen, reacting for 5h at 120 ℃ and 3MPa, filtering, and distilling to obtain the cyclic diol; the Raney nickel accounts for 6.25 percent of the weight of the dialdehyde intermediate; the cyclic diol is shown as follows:
Figure BDA0002596514620000101
R1is a hydrogen atom;
the hydrogen spectrum of the cyclic diol is as follows: 1HNMR (CDCl3),1.02-1.08(m,2H), 1.26-1.41(m,3H), 1.92-1.98(m,2H), 2.11-2.21(m,3H), 2.96-3.11(m,1H), 3.31-3.36(m, 2H).
Example 2
This example provides a method for preparing a cyclic diol having a bridged ring structure, comprising:
cycloaddition: under the protection of nitrogen, mixing 1, 3-cyclohexadiene, methacrolein, tetramethyl piperidine nitroxide free radical phosphite triester and dichloromethane, adding trityl tetrafluoroborate, reacting at 23 ℃ for 10 ℃, cooling to room temperature, washing with water, desolventizing, and rectifying under reduced pressure to obtain the monoaldehyde cycloolefine; the molar ratio of the 1, 3-cyclohexadiene to methacrolein is 1: 1.2, the mole percentage of the trityl tetrafluoroborate to the 1, 3-cyclohexadiene is 1.9%, and the weight percentage of the tetramethyl piperidine nitroxide radical phosphite triester to the methacrolein is 0.25 wt%; the monoaldehyde cycloalkene is shown below:
Figure BDA0002596514620000102
R2is methyl;
hydroformylation: adding the mono-aldehyde cycloolefin and tetrahydrofuran into a hydroformylation reaction kettle, adding a hydroformylation catalyst, replacing air in the reaction kettle with synthesis gas, reacting for 3 hours at the temperature of 110 ℃ under the pressure of 2MPa, and distilling under reduced pressure to obtain a dialdehyde intermediate; in the synthesis gas, CO and H2Is 1: 1, the hydroformylation catalyst is a composition of rhodium octoate and triphenyl phosphite, and the molar ratio is 1: 5.44, the molar concentration of rhodium octanoate in monoaldehyde cycloolefin is 58.83 ppm; the dialdehyde intermediate is shown as follows:
Figure BDA0002596514620000103
R2is methyl;
catalytic hydrogenation: adding the dialdehyde intermediate, tetrahydrofuran and a catalytic hydrogenation catalyst into a catalytic hydrogenation reaction kettle, replacing air in the reaction kettle with hydrogen, reacting for 5 hours at 120 ℃ and 2MPa, filtering and distilling to obtain the cyclic diol; the catalytic hydrogenation catalyst is a supported catalytic hydrogenation catalyst and comprises palladium and activated carbon, wherein the palladium accounts for 5 wt% of the supported catalytic hydrogenation catalyst, and the catalytic hydrogenation catalyst accounts for 5 wt% of the dialdehyde intermediate; the cyclic diol is shown as follows:
Figure BDA0002596514620000111
R2is methyl.
The hydrogen spectrum of the cyclic diol is as follows: 1HNMR (CDCl3), 1.13-1.16(m,3H), 1.22-1.32(m,2H), 1.42-1.66(m,5H), 1.81-1.92(m,4H), 2.95-3.01(m,2H), 3.36-3.45(m, 2H).
Example 3
This example provides a method for preparing a cyclic diol having a bridged ring structure, comprising:
cycloaddition: under the protection of nitrogen, mixing 1, 3-cyclohexadiene, acrolein, tetramethylpiperidine nitroxide free radical phosphite triester and dichloromethane, adding trityl hexafluoroborate, reacting at 40 ℃ for 12 hours, cooling to room temperature, washing with water, desolventizing, and rectifying under reduced pressure to obtain the monoaldehyde cycloolefins; the molar ratio of the 1, 3-cyclohexadiene to the acrolein is 1: 1.2, the mole percentage of the trityl hexafluoroborate to the 1, 3-cyclohexadiene is 1.6%, and the weight percentage of the tetramethyl piperidine nitroxide radical phosphite triester to the acrolein is 0.25 wt%; the monoaldehyde cycloalkene is shown below:
Figure BDA0002596514620000112
R2is a hydrogen atom;
hydroformylation: adding the mono-aldehyde cycloolefin and tetrahydrofuran into a hydroformylation reaction kettle, adding a hydroformylation catalyst, replacing air in the reaction kettle with synthesis gas, reacting for 3 hours at the temperature of 120 ℃ under the pressure of 2MPa, and distilling under reduced pressure to obtain a dialdehyde intermediate; in the synthesis gas, CO and H2Is 1: 1, the hydroformylation catalyst is a composition of rhodium acetate and triphenylphosphine, and the molar ratio is 1: 8, the molar concentration of rhodium acetate in the monoaldehyde cycloolefins is 85 ppm; the dialdehyde intermediate is shown as follows:
Figure BDA0002596514620000113
R2is a hydrogen atom;
catalytic hydrogenation: adding the dialdehyde intermediate, tetrahydrofuran and raney nickel into a catalytic hydrogenation reaction kettle, replacing air in the reaction kettle with hydrogen, reacting for 5h at 120 ℃ and 3MPa, filtering, and distilling to obtain the cyclic diol; the Raney nickel accounts for 5 percent of the weight of the dialdehyde intermediate; the cyclic diol is shown as follows:
Figure BDA0002596514620000114
R2is a hydrogen atom.
The hydrogen spectrum of the cyclic diol is as follows: 1HNMR (CDCl3), 1.16-1.32(m,2H), 1.38-1.68(m,5H), 1.83-1.88(m,3H), 2.92-3.05(m,2H), 3.32-3.45(m, 2H).
Example 4
This example provides a method for preparing a cyclic diol having a bridged ring structure, comprising:
cycloaddition: under the protection of nitrogen, mixing cyclopentadiene, methacrolein, tetramethyl piperidine nitroxyl free radical phosphite triester and toluene, adding bis- (trifluorosulfonyl) -imidosilane, reacting at 65 ℃ for 9 hours, cooling to room temperature, washing with water, desolventizing, and rectifying under reduced pressure to obtain the monoaldehyde cycloolefin; the mol ratio of the cyclopentadiene to the methacrolein is 1: 1.2, the mol percentage of the bis- (trifluorosulfonyl) -imido silane to the cyclopentadiene is 1.6 percent, and the weight percentage of the tetramethyl piperidine nitroxide radical phosphite triester to the methacrolein is 0.25 percent; the monoaldehyde cycloalkene is shown below:
Figure BDA0002596514620000121
R1is methyl;
hydroformylation: adding the mono-aldehyde cycloolefin and the toluene into a hydroformylation reaction kettle, adding a hydroformylation catalyst, replacing air in the reaction kettle with synthesis gas, reacting for 3 hours at the temperature of 120 ℃ under the pressure of 2MPa, and distilling under reduced pressure to obtain a dialdehyde intermediate; in the synthesis gas, CO and H2Is 1: 1, the hydroformylation catalyst is dicarbonyl ethylA composition of rhodium acetylacetonate and triphenyl phosphite in a molar ratio of 1: 6, the molar concentration of the dicarbonyl acetylacetone rhodium in the monoaldehyde cycloolefin is 67 ppm; the dialdehyde intermediate is shown as follows:
Figure BDA0002596514620000122
R1is methyl;
catalytic hydrogenation: adding the dialdehyde intermediate, toluene and a catalytic hydrogenation catalyst into a catalytic hydrogenation reaction kettle, replacing air in the reaction kettle with hydrogen, reacting for 5h at 120 ℃ and 2MPa, filtering and distilling to obtain the cyclic diol; the catalytic hydrogenation catalyst is a supported catalytic hydrogenation catalyst and comprises palladium and activated carbon, wherein the palladium accounts for 5 wt% of the supported catalytic hydrogenation catalyst, and the catalytic hydrogenation catalyst accounts for 5 wt% of the dialdehyde intermediate; the cyclic diol is shown as follows:
Figure BDA0002596514620000123
R1is methyl.
The hydrogen spectrum of the cyclic diol is as follows: 1HNMR (CDCl3),1.08-1.14(m,3H), 1.22-1.38(m,2H), 1.83-1.95(m,3H), 1.97-2.14(m,2H), 2.74-3.03(m,2H), 3.13-3.24(m,4H)
Example 5
This example provides a process for producing a cyclic diol having a bridged ring structure, which is carried out in the same manner as in example 2, except that the molar ratio of 1, 3-cyclohexadiene to methacrolein is 1: 1.8.
example 6
This example provides a process for producing a cyclic diol having a bridged ring structure, which is similar to example 2, except that trityltetrafluoroborate is replaced with N-methylimidazolidone.
Example 7
This example provides a method for preparing a cyclic diol containing a bridged ring structure, which is similar to example 2, except that triphenyl phosphite is replaced with trihexyl phosphite.
Example 8
This example provides a method for preparing a cyclic diol having a bridged ring structure, which is similar to example 2, except that the reaction temperature in the catalytic hydrogenation is 180 ℃.
Example 9
This example provides a method for preparing cyclic diol containing bridged ring structure, which is similar to example 2, except that the reaction time in the catalytic hydrogenation is 10 h.
Evaluation of Performance
The following experiments were performed as experimental groups provided in the examples.
1. Yield: the preparation of cyclic diols was carried out according to the preparation methods provided in the examples, and the yields of monoaldehyde cycloalkenes, dialdehyde intermediates and cyclic diols were calculated, and the results are shown in table 1.
2. Purity: the preparation of cyclic diols was carried out according to the preparation methods provided in the examples, and the purity of cyclic diols was tested according to gas chromatography, with the results shown in table 1.
Table 1 performance characterization test
Figure BDA0002596514620000131
Figure BDA0002596514620000141
The test results in table 1 show that the preparation method of the cyclic diol containing bridged ring structure provided by the invention has simple process, and the prepared cyclic diol has high yield and purity, and can be used for synthesis and modification of various macromolecules.
The foregoing examples are merely illustrative and serve to explain some of the features of the method of the present invention. The appended claims are intended to claim as broad a scope as is contemplated, and the examples presented herein are merely illustrative of selected implementations in accordance with all possible combinations of examples. Accordingly, it is applicants' intention that the appended claims are not to be limited by the choice of examples illustrating features of the invention. Also, where numerical ranges are used in the claims, subranges therein are included, and variations in these ranges are also to be construed as possible being covered by the appended claims.

Claims (10)

1. A preparation method of cyclic diol containing a bridged ring structure is characterized in that the cyclic diol is represented by formula (1) and/or formula (2):
Figure FDA0002596514610000011
R1、R2respectively hydrogen atom or C1-C6 alkyl.
2. The method for preparing the cyclic diol containing the bridged ring structure according to claim 1, wherein the cyclic diol is obtained by catalytic hydrogenation of a dialdehyde intermediate, and the dialdehyde intermediate is represented by formula (3) and/or formula (4):
Figure FDA0002596514610000012
R1、R2respectively hydrogen atom or C1-C6 alkyl.
3. The method for preparing cyclic diol containing a bridged ring structure according to claim 2, wherein in the catalytic hydrogenation, the reaction pressure is 1-10 MPa, and the reaction temperature is 80-150 ℃.
4. The method for preparing cyclic diol containing bridged ring structure according to claim 2, wherein the dialdehyde intermediate is obtained by hydroformylation of monoaldehyde cycloolefins, and the monoaldehyde cycloolefins are represented by formula (5) and/or formula (6):
Figure FDA0002596514610000013
R1、R2respectively hydrogen atom or C1-C6 alkyl.
5. The method of claim 4, wherein the hydroformylation comprises reacting a monoaldehyde cyclic olefin with syngas in the presence of a hydroformylation catalyst to obtain a dialdehyde intermediate.
6. The method for preparing cyclic diol containing bridged ring structure according to claim 4, wherein the hydroformylation is carried out under a reaction pressure of 1-5 MPa and at a reaction temperature of 90-150 ℃.
7. The method for producing a cyclic diol having a bridged ring structure according to claim 5, wherein the hydroformylation catalyst is a combination of a metal salt and an organic phosphorus.
8. The method for preparing the cyclic diol containing the bridged ring structure according to any one of claims 4 to 7, wherein the monoaldehyde cyclic olefin is obtained by cycloaddition of a cyclic diene and a monoolefin aldehyde, wherein the cyclic diene is cyclopentadiene and/or 1, 3-cyclohexadiene, and the monoolefin aldehyde is represented by the formula (7):
Figure FDA0002596514610000021
r is hydrogen atom or C1-C6 alkyl.
9. The method according to claim 8, wherein the molar ratio of the cyclic diene to the monoalkene aldehyde is 1: (1-1.5).
10. Use of the cyclic diol having a bridged ring structure according to any one of claims 1 to 9 for the preparation of a polymer.
CN202010710922.7A 2020-07-22 2020-07-22 Preparation method and application of cyclic diol containing bridged ring structure Pending CN111825524A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010710922.7A CN111825524A (en) 2020-07-22 2020-07-22 Preparation method and application of cyclic diol containing bridged ring structure

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010710922.7A CN111825524A (en) 2020-07-22 2020-07-22 Preparation method and application of cyclic diol containing bridged ring structure

Publications (1)

Publication Number Publication Date
CN111825524A true CN111825524A (en) 2020-10-27

Family

ID=72924729

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010710922.7A Pending CN111825524A (en) 2020-07-22 2020-07-22 Preparation method and application of cyclic diol containing bridged ring structure

Country Status (1)

Country Link
CN (1) CN111825524A (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101497561A (en) * 2008-01-29 2009-08-05 财团法人工业技术研究院 Hydroformylation process
JP2011074178A (en) * 2009-09-30 2011-04-14 Sanyo Chem Ind Ltd Polyurethane resin aqueous dispersion

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101497561A (en) * 2008-01-29 2009-08-05 财团法人工业技术研究院 Hydroformylation process
JP2011074178A (en) * 2009-09-30 2011-04-14 Sanyo Chem Ind Ltd Polyurethane resin aqueous dispersion

Similar Documents

Publication Publication Date Title
US3687981A (en) Process for making a dioxane
KR101985035B1 (en) Integrated process for the preparation of 1,4-cyclohexanedimethanol from terephtalic acid
EP0049631B1 (en) Polycyclic alcohols
EP3696160B1 (en) Extraction process for high-boiling aldehyde product separation and catalyst recovery
KR101985034B1 (en) Process for the preparation of 1,4-cyclohexanedimethanol from terephthalic acid
EP2236530B1 (en) Modified naphthalene formaldehyde resin, tricyclodecane skeleton-containing naphthol compound and ester compound
KR101985036B1 (en) Process for the preparation of 1,4-cyclohexanedimethanol
EP2210907A1 (en) Polyfunctional dimethylnaphthalene formaldehyde resin, and process for production thereof
Ohno et al. Organic syntheses by means of noble metal compounds—XLVII: Reaction of butadiene with aldehydes and ketones catalyzed by palladium-phosphine complexes
US4026960A (en) 2,7,10,15,18,23-Hexamethyltetra-cosane
CA2092040A1 (en) Decyl alcohol mixtures, phthalic esters obtainable therefrom and their use as plasticizers
CN111825524A (en) Preparation method and application of cyclic diol containing bridged ring structure
JPH0819028B2 (en) Hydroformylation method
JPWO2005080364A1 (en) Method for producing alicyclic oxetane compound
US3506722A (en) Di(hydroxymethyl)methyl-cyclopentanes
US5952533A (en) Method of producing 1,6-hexane diol from epoxybutadiene
CN113072431A (en) High-selectivity synthesis method of propylene glycol phenyl ether
KR102444853B1 (en) Tricyclodecane dimethanol composition and preparation method of the same
US4505860A (en) Cyclic keto-butyraldehydes a process for their preparation, and their use in the preparation of cyclic diisocyanates
JP7247817B2 (en) Dialdehyde compound having norbornane skeleton and cyclohexadione skeleton and method for producing the same
KR102435356B1 (en) Tricyclodecane dimethanol composition and preparation method of the same
KR102627153B1 (en) Pentacyclopentadecane dimethanol products
WO2022255125A1 (en) Pentacyclopentadecane dimethanol product
GB2089790A (en) Preparation of ethylene glycol and ethers thereof
JPH0344342A (en) Alcohol for plasticizer

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
TA01 Transfer of patent application right

Effective date of registration: 20230413

Address after: 525000 North Huanshi Road, Maonan District, Maoming City, Guangdong Province, 59-3 (in Maonan Petrochemical Industrial Park)

Applicant after: GUANGDONG CPD NEW MATERIAL TECHNOLOGY Co.,Ltd.

Address before: 525000 Guangdong city in Maoming Province four City Road No. 18

Applicant before: GUANGDONG XINHUAYUE PETROCHEMICAL INCORPORATED CO.

TA01 Transfer of patent application right
RJ01 Rejection of invention patent application after publication

Application publication date: 20201027

RJ01 Rejection of invention patent application after publication